Innovation Pharmaceuticals’ Phase 2 Clinical Trial of Brilacidin for Treating COVID-19 Scheduled to Begin Next Week

NEXT STORY
Global Fluoroscopy Equipment Market – Growing demand for data – integrated imaging systems, Advantages of FPDs over image intensifiers driving market growth – by PMI
PREV STORY
Turning Point Therapeutics Reports Updated Interim Data From Registrational Phase 2 Trident-1 Study of Repotrectinib in Patients With ROS1-Positive TKI-Naïve Non-Small Cell Lung Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aptevo Therapeutics Announces Plans to Conduct Phase 2 Study of Otlertuzumab in Peripheral T-Cell Lymphoma

Anticipates 2 IND Filings in 2018 for Novel Bispecific Antibody Candidates SEATTLE, Nov. 28, ...

author_avatar
NASDAQ Market News

Global biochip market was valued at USD11694.24 million in 2020 and is expected to reach USD23890.58 million by 2026

author_avatar
NASDAQ Market News

Chembio Diagnostics and Takeda Pharmaceutical Complete Feasibility Study

author_avatar
NASDAQ Market News